ET
CRL icon

Equitable Trust’s Charles River Laboratories CRL Stock Holding History

Equitable Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,423
Closed -$447K – 465
2024
Q4 		$447K Hold
2,423
– – 0.03% 340
2024
Q3 		$477K Sell
2,423
-43
-2% -$8.94K 0.03% 324
2024
Q2 		$509K Hold
2,466
– – 0.04% 293
2024
Q1 		$668K Buy
2,466
+184
+8% +$43.9K 0.05% 249
2023
Q4 		$539K Buy
2,282
+576
+34% +$113K 0.04% 267
2023
Q3 		$334K Hold
1,706
– – 0.03% 324
2023
Q2 		$359K Sell
1,706
-229
-12% -$45.6K 0.03% 314
2023
Q1 		$391K Sell
1,935
-213
-10% -$48.3K 0.03% 297
2022
Q4 		$468K Buy
+2,148
New +$469K 0.04% 272

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return